Financiel contribution for travel to French-Swedish Life science day 2017, Paris, France
| Reference number | |
| Coordinator | GLUCOX BIOTECH AB |
| Funding from Vinnova | SEK 3 806 |
| Project duration | December 2017 - May 2018 |
| Status | Completed |
| Venture | Travel grant |
| Call | Travel grant for building international consortia |
Important results from the project
The project aimed at participation in a conference arranged at the Swedish embassy in Paris, French-Swedish Life Science Day 2017, in order to present Glucox Biotech AB, to French investors and to establish business contacts among the participants.
Expected long term effects
Glucox` R&D activities and business strategy were pressed and discussed with the intention to find further financing for the continued development of the Company. Accordingly, one-to-one meetings were held with Claire Poulard, analyst at Omnes Capital, Paris, Amelia Graciet, dealflow manager at Angels Satte, Paris samt Arnaud Autet, associate at Seventure Partners, Paris. The follow-up of the meetings is now part of the Companies ordinary business development work.
Approach and implementation
The structure of the conference was divided between presentations and one-to-one meetings in a very pleasant environment in the Swedish Embassy in Paris. The meetings were booked electronically well in advance of the conference. Everything worked very well and the time schedule was adhered to perfectly.